A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients

Exclusion Criteria

• •Previous history of life-threatening asthma, respiratory tract infection and/or exacerbation of asthma within 6 weeks prior to the first screening visit
• •History of being unable to tolerate or complete an exercise challenge and clinically significant multiple drug or food allergies
• •Past or present disorders and diseases including, but are not limited to cardiovascular, malignancy, hepatic, renal, hematological, neurological, psychiatric, endocrine, or pulmonary other than asthma
• •Patients with Seasonal Allergic Rhinitis (SAR) or seasonal allergic asthma,with significant symptoms that may confound study assessment
• •Significant safety laboratory, ECG, or vital sign abnormalities that would place the patient at undue risk during the study procedures